Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality-Score (Q-Score) Can Be More Sensitive than %Time in Range and Several Other CGM Metrics in Detecting Responses to Therapeutic Interventions.

Diabetes technology & therapeutics·2026
Same author

Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring.

Diabetes, obesity & metabolism·2025
Same author

Response to Sensitivity of the Glycemia Risk Index to Effects of Automated Insulin Delivery Initiation.

Journal of diabetes science and technology·2023
Same author

Association between glycaemia risk index (GRI) and diabetic retinopathy in type 2 diabetes: A cohort study.

Diabetes, obesity & metabolism·2023
Same author

Proof-of-concept Application of Continuous Glucose Monitoring Data Analytics to Identify Diabetes Glucotypes.

Journal of the Endocrine Society·2023
Same author

Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.

Diabetes, obesity & metabolism·2022
Same journal

Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes.

Diabetes technology & therapeutics·2026
Same journal

Invited Commentary: Using Large Clinical Databases.

Diabetes technology & therapeutics·2026
Same journal

Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study.

Diabetes technology & therapeutics·2026
Same journal

Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study.

Diabetes technology & therapeutics·2026
Same journal

<i>Letter:</i> "Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting".

Diabetes technology & therapeutics·2026
Same journal

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Diabetes technology & therapeutics·2026
See all related articles

Related Experiment Video

Updated: May 11, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Standardization versus customization of glucose reporting.

David Rodbard1

  • 1Biomedical Informatics Consultants LLC, Potomac, Maryland, MD 20854-4721, USA. drodbard@comcast.net

Diabetes Technology & Therapeutics
|May 3, 2013
PubMed
Summary
This summary is machine-generated.

Standardizing continuous glucose monitoring (CGM) and self-monitoring of blood glucose (SMBG) data analysis, like the ambulatory glucose profile (AGP), is crucial. This standardization aims to improve glycemic variability assessment and clinical decision support, despite challenges in diverse platforms.

More Related Videos

Bergmeyer Glucose Quantification for Microbiological Samples
07:23

Bergmeyer Glucose Quantification for Microbiological Samples

Published on: January 17, 2025

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis
12:02

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis

Published on: April 11, 2016

Related Experiment Videos

Last Updated: May 11, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Bergmeyer Glucose Quantification for Microbiological Samples
07:23

Bergmeyer Glucose Quantification for Microbiological Samples

Published on: January 17, 2025

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis
12:02

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis

Published on: April 11, 2016

Area of Science:

  • Diabetes Technology
  • Metabolic Monitoring
  • Clinical Data Analysis

Background:

  • The ambulatory glucose profile (AGP) offers a valuable method for analyzing continuous glucose monitoring (CGM) and self-monitoring of blood glucose (SMBG) data.
  • While informative, the AGP has limitations, and other graphical displays can provide complementary insights.
  • Standardization of glycemic variability parameters and validation of analysis software are needed.

Purpose of the Study:

  • To discuss the importance of standardizing the reporting and analysis of CGM and SMBG data.
  • To highlight the utility and limitations of the ambulatory glucose profile (AGP).
  • To address the need for standardizing glycemic variability metrics and validating computational tools.

Main Methods:

  • Review of existing graphical methods for glucose data display, including the AGP.
  • Discussion of potential enhancements, such as meal synchronization for postprandial analysis.
  • Exploration of the role of clinical decision support software in interpreting glucose data.

Main Results:

  • The AGP is a powerful tool for visualizing glucose trends but may benefit from variations and complementary displays.
  • Standardization of glycemic variability parameters and cross-validation of software are necessary for reliable analysis.
  • Clinical decision support systems can aid in therapy adjustments based on glucose data.

Conclusions:

  • Standardization of glucose monitoring data analysis, including AGP and glycemic variability, is essential for clinical practice.
  • Flexibility and innovation must be balanced with standardization to accommodate diverse clinical needs and technological platforms.
  • Further development is needed to create universally accepted standards for glucose data analysis and interpretation.